Chesapeake Pharmaceutical is categorized under Paperboard Mills in Evansville, IN .
Chesapeake Pharmaceutical was established in 0, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Paperboard Mills business, which does work in the BOTH market, and is classified as a Paperboard Mills, under code number 5619100 by the NAICS.
If you are seeking more information, feel free to contact John Miles, General Manager at the company’s branch by writing to 15220 Foundation Avenue, Evansville, Indiana IN 47725 or by phoning (812) 422-4104. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Chesapeake Pharmaceutical |
| Contact Person: | John Miles, General Manager |
| Address: | 15220 Foundation Avenue, Evansville, Indiana 47725 |
| Phone Number: | (812) 422-4104 |
| Website Address: | chesapeakecorp.com |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Paperboard Mills |
| SIC Code: | 2631 |
| NAICS Code: | 5619100 |
| Share This Business: |
Chesapeake Pharmaceutical was started in 0 to provide professional Paperboard Mills under the SIC code 2631 and NAICS code 5619100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact John Miles, General Manager for inquiries that concern Chesapeake Pharmaceutical by calling the company number (812) 422-4104, as your correspondence is most welcome. Additionally, the physical location of the branch of Chesapeake Pharmaceutical can be found at the coordinates 38.11487,-87.48528 as well as the street address 15220 Foundation Avenue in Evansville, Indiana 47725.
For its online presence, you may visit Chesapeake Pharmaceutical’s website at chesapeakecorp.com and engage with its social media outlets through on Twitter and on Facebook.